Institution
Lenox Hill Hospital
Healthcare•New York, New York, United States•
About: Lenox Hill Hospital is a healthcare organization based out in New York, New York, United States. It is known for research contribution in the topics: Population & Stent. The organization has 2569 authors who have published 3561 publications receiving 114326 citations.
Topics: Population, Stent, Arthroplasty, Angioplasty, Myocardial infarction
Papers published on a yearly basis
Papers
More filters
••
TL;DR: In patients presenting within 24 hours of the development of CGS, TandemHeart significantly improves hemodynamic parameters, even in patients failing IABP, and larger-scale studies are required to assess the influence of improved hemodynamics on survival.
503 citations
••
TL;DR: Bone marrow cells secrete angiogenic factors that induce endothelial cell proliferation and, when injected transendocardially, augment collateral perfusion and myocardial function in ischemic myocardium.
502 citations
••
TL;DR: Femoropopliteal peripheral artery disease treatment with the paclitaxel-eluting stent was associated with superior 12-month outcomes compared with PTA and provisional bare metal stent placement.
Abstract: Background—Sustained benefits of drug-eluting stents in femoropopliteal arteries have not been demonstrated. This prospective, multinational, randomized study was designed to compare the 12-month safety and effectiveness of a polymer-free, paclitaxel-coated nitinol drug-eluting stent (DES) with percutaneous transluminal angioplasty (PTA) and provisional bare metal stent (BMS) placement in patients with femoropopliteal peripheral artery disease. Methods and Results—Patients were randomly assigned to primary DES implantation (n=236) or PTA (n=238). Demographics and lesion characteristics were similar between groups (eg, average lesion length, approximately 65±40 mm). One hundred twenty patients had acute PTA failure and underwent secondary random assignment to provisional DES (n=61) or BMS (n=59). Primary end points were the 12-month rates of event-free survival and patency in the primary DES and PTA groups. Compared with the PTA group, the primary DES group exhibited superior 12-month event-free survival (...
482 citations
••
TL;DR: Preliminary clinical data indicates feasibility of catheter-based transendocardial delivery of ABM to ischemic myocardium in patients with severe symptomatic chronic myocardial ischemia not amenable to conventional revascularization.
455 citations
••
TL;DR: The authors' data lend strong support to 3-dimensional cross-sectional measures, using CT as the new gold standard for aortic annular evaluation for TAVR with the Edwards SAPIEN device.
446 citations
Authors
Showing all 2596 results
Name | H-index | Papers | Citations |
---|---|---|---|
Martin B. Leon | 163 | 1400 | 129393 |
Richard B. Devereux | 144 | 962 | 116403 |
Roxana Mehran | 141 | 1378 | 99398 |
Kenneth Offit | 122 | 576 | 46548 |
Alexandra J. Lansky | 114 | 632 | 54445 |
Joshua J. Jacobs | 107 | 455 | 34463 |
George Dangas | 102 | 773 | 41137 |
Jeffrey W. Moses | 100 | 571 | 58868 |
Michael J. Pencina | 100 | 419 | 55000 |
Roberto M. Lang | 96 | 823 | 56638 |
Scott C. Weaver | 92 | 536 | 32230 |
Michael A. Mont | 86 | 1072 | 32026 |
Michael R. Jaff | 82 | 442 | 28891 |
Stephen J. Meltzer | 82 | 276 | 24789 |
Jack Wang | 79 | 211 | 18756 |